Corrigendum to “Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies” [The Lancet Regional Health–Western Pacific, Volume 50, September 2024, 101183]

IF 7.6 1区医学 Q1 HEALTH CARE SCIENCES & SERVICES

The Lancet Regional Health: Western Pacific Pub Date : 2024-11-01 DOI:10.1016/j.lanwpc.2024.101249

Claire O’Callaghan , Johannes C. Michaelian , Yoko Aihara , Veeda Michelle Anlacan , Christopher Chen , Gary Cheung , Etuini Ma’u , Tuan Anh Nguyen , Ming-Chyi Pai , Anna Palagyi , Maw Pin Tan , Shyh Poh Teo , Yuda Turana , Huali Wang , Gloria Wong , Sharon L. Naismith

引用次数: 0

查看原文本刊更多论文

西太平洋地区痴呆症诊断和治疗服务：面对淀粉样蛋白靶向疗法的挑战、准备情况和机遇》更正[《柳叶刀区域健康-西太平洋》，第50卷，2024年9月，101183]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet Regional Health: Western Pacific Medicine-Pediatrics, Perinatology and Child Health

CiteScore

8.80

自引率

2.80%

发文量

305

审稿时长

11 weeks

期刊介绍： The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.